Contribution of Hepatic and Intestinal Lipoproteins to Human Atherosclerosis

NCT01321476 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2013-09-05

No results posted yet for this study

Summary

This study will use excess tissue from endoscopic or surgical procedures to examine the elements of plaque that are found in the carotid walls of patients who have a type of heart and blood vessel disease called atherosclerosis. Tissue will be collected from patients undergoing carotid procedures as well as patients undergoing liver and/or intestinal biopsies. This lab study will examine the different types of proteins that play a role in developing heart plaque.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Joseph Miller, MD · Piedmont Heart Institute/Piedmont Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01321476 on ClinicalTrials.gov